vs

Side-by-side financial comparison of Ameris Bancorp (ABCB) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Ameris Bancorp is the larger business by last-quarter revenue ($314.4M vs $269.1M, roughly 1.2× Inspire Medical Systems, Inc.). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs 35.1%, a 15.4% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs 10.0%). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs 2.3%).

Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

ABCB vs INSP — Head-to-Head

Bigger by revenue
ABCB
ABCB
1.2× larger
ABCB
$314.4M
$269.1M
INSP
Growing faster (revenue YoY)
INSP
INSP
+2.3% gap
INSP
12.2%
10.0%
ABCB
Higher net margin
INSP
INSP
15.4% more per $
INSP
50.6%
35.1%
ABCB
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
2.3%
ABCB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ABCB
ABCB
INSP
INSP
Revenue
$314.4M
$269.1M
Net Profit
$110.5M
$136.1M
Gross Margin
86.6%
Operating Margin
17.1%
Net Margin
35.1%
50.6%
Revenue YoY
10.0%
12.2%
Net Profit YoY
286.4%
EPS (diluted)
$1.63
$4.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCB
ABCB
INSP
INSP
Q1 26
$314.4M
Q4 25
$307.1M
$269.1M
Q3 25
$314.2M
$224.5M
Q2 25
$300.7M
$217.1M
Q1 25
$285.9M
$201.3M
Q4 24
$290.8M
$239.7M
Q3 24
$283.8M
$203.2M
Q2 24
$300.6M
$195.9M
Net Profit
ABCB
ABCB
INSP
INSP
Q1 26
$110.5M
Q4 25
$108.4M
$136.1M
Q3 25
$106.0M
$9.9M
Q2 25
$109.8M
$-3.6M
Q1 25
$87.9M
$3.0M
Q4 24
$94.4M
$35.2M
Q3 24
$99.2M
$18.5M
Q2 24
$90.8M
$9.8M
Gross Margin
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
86.6%
Q3 25
85.8%
Q2 25
84.0%
Q1 25
84.7%
Q4 24
85.0%
Q3 24
84.1%
Q2 24
84.8%
Operating Margin
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
45.9%
17.1%
Q3 25
43.6%
4.3%
Q2 25
47.4%
-1.5%
Q1 25
39.5%
-0.7%
Q4 24
43.3%
13.3%
Q3 24
44.4%
7.0%
Q2 24
42.1%
2.6%
Net Margin
ABCB
ABCB
INSP
INSP
Q1 26
35.1%
Q4 25
44.2%
50.6%
Q3 25
33.7%
4.4%
Q2 25
36.5%
-1.7%
Q1 25
30.8%
1.5%
Q4 24
42.5%
14.7%
Q3 24
35.0%
9.1%
Q2 24
30.2%
5.0%
EPS (diluted)
ABCB
ABCB
INSP
INSP
Q1 26
$1.63
Q4 25
$1.59
$4.57
Q3 25
$1.54
$0.34
Q2 25
$1.60
$-0.12
Q1 25
$1.27
$0.10
Q4 24
$1.35
$1.17
Q3 24
$1.44
$0.60
Q2 24
$1.32
$0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCB
ABCB
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$308.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.1B
$781.2M
Total Assets
$28.1B
$907.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
$308.3M
Q3 25
$322.6M
Q2 25
$300.9M
Q1 25
$369.2M
Q4 24
$445.5M
Q3 24
$411.0M
Q2 24
$439.7M
Stockholders' Equity
ABCB
ABCB
INSP
INSP
Q1 26
$4.1B
Q4 25
$4.1B
$781.2M
Q3 25
$4.0B
$666.5M
Q2 25
$3.9B
$677.8M
Q1 25
$3.8B
$635.7M
Q4 24
$3.8B
$689.7M
Q3 24
$3.7B
$696.6M
Q2 24
$3.6B
$638.1M
Total Assets
ABCB
ABCB
INSP
INSP
Q1 26
$28.1B
Q4 25
$27.5B
$907.3M
Q3 25
$27.1B
$807.7M
Q2 25
$26.7B
$802.2M
Q1 25
$26.5B
$730.8M
Q4 24
$26.3B
$808.4M
Q3 24
$26.4B
$796.2M
Q2 24
$26.5B
$728.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCB
ABCB
INSP
INSP
Operating Cash FlowLast quarter
$52.5M
Free Cash FlowOCF − Capex
$41.8M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
$390.2M
$52.5M
Q3 25
$104.9M
$68.5M
Q2 25
$61.4M
$2.7M
Q1 25
$116.9M
$-6.7M
Q4 24
$154.2M
$69.2M
Q3 24
$102.2M
$52.3M
Q2 24
$-97.1M
$-78.0K
Free Cash Flow
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
$369.6M
$41.8M
Q3 25
$100.5M
$58.1M
Q2 25
$53.7M
$-6.3M
Q1 25
$114.2M
$-15.1M
Q4 24
$140.7M
$62.2M
Q3 24
$99.8M
$44.3M
Q2 24
$-100.3M
$-12.5M
FCF Margin
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
120.4%
15.5%
Q3 25
32.0%
25.9%
Q2 25
17.9%
-2.9%
Q1 25
39.9%
-7.5%
Q4 24
48.4%
25.9%
Q3 24
35.2%
21.8%
Q2 24
-33.4%
-6.4%
Capex Intensity
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
6.7%
4.0%
Q3 25
1.4%
4.6%
Q2 25
2.5%
4.1%
Q1 25
0.9%
4.2%
Q4 24
4.6%
2.9%
Q3 24
0.8%
3.9%
Q2 24
1.1%
6.3%
Cash Conversion
ABCB
ABCB
INSP
INSP
Q1 26
Q4 25
3.60×
0.39×
Q3 25
0.99×
6.90×
Q2 25
0.56×
Q1 25
1.33×
-2.24×
Q4 24
1.63×
1.96×
Q3 24
1.03×
2.83×
Q2 24
-1.07×
-0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons